Alterity Therapeutics Files 6-K Report
Ticker: ATHE · Form: 6-K · Filed: Apr 22, 2026 · CIK: 0001131343
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-issuer
TL;DR
Alterity Therapeutics filed a 6-K on 4/22/26 for the period ending 4/30/26. Standard update.
AI Summary
Alterity Therapeutics Ltd. filed a 6-K report on April 22, 2026, for the period ending April 30, 2026. The filing includes form 6-K documents and exhibits, with the primary document being 'athe20260422_6k.htm'. The company's business and mailing addresses are both located at Level 3, 460 Bourke Street, Melbourne, Australia.
Why It Matters
This filing provides routine updates from a foreign issuer, Alterity Therapeutics Ltd., to the SEC, offering transparency on their reporting period.
Risk Assessment
Risk Level: low — This is a routine 6-K filing, typically containing standard corporate disclosures and not indicating significant new risks.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Filer
- 0001131343 (company) — CIK
- 2026-04-22 (date) — Filing Date
- 2026-04-30 (date) — Period of Report
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a Report of foreign issuer.
Who is the filer of this report?
The filer is Alterity Therapeutics Ltd.
What is the CIK number for Alterity Therapeutics Ltd.?
The CIK number for Alterity Therapeutics Ltd. is 0001131343.
When was this filing accepted by the SEC?
This filing was accepted on April 22, 2026.
What is the period of report for this filing?
The period of report is April 30, 2026.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 22, 2026 regarding ALTERITY THERAPEUTICS LTD (ATHE).